Design of siRNA Therapeutics from the Molecular Scale

While protein-based therapeutics is well-established in the market, development of nucleic acid therapeutics has lagged. Short interfering RNAs (siRNAs) represent an exciting new direction for the pharmaceutical industry. These small, chemically synthesized RNAs can knock down the expression of targ...

Descripción completa

Detalles Bibliográficos
Autores principales: Angart, Phillip, Vocelle, Daniel, Chan, Christina, Walton, S. Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749788/
https://www.ncbi.nlm.nih.gov/pubmed/23976875
http://dx.doi.org/10.3390/ph6040440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749788/
https://www.ncbi.nlm.nih.gov/pubmed/23976875
http://dx.doi.org/10.3390/ph6040440

Ejemplares similares